Topical ruxolitinib for the treatment of granuloma faciale
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_1f2f710fa0a846978f686f95b8bdce8b | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Alan Wong, DO |e author |
| 700 | 1 | 0 | |a Samuel Stahly, DO |e author |
| 700 | 1 | 0 | |a Jason Kieffer, MD |e author |
| 700 | 1 | 0 | |a Charles Dunn, MD |e author |
| 700 | 1 | 0 | |a Rajiv Nathoo, MD |e author |
| 245 | 0 | 0 | |a Topical ruxolitinib for the treatment of granuloma faciale |
| 260 | |b Elsevier, |c 2023-06-01T00:00:00Z. | ||
| 500 | |a 2352-5126 | ||
| 500 | |a 10.1016/j.jdcr.2023.04.013 | ||
| 546 | |a EN | ||
| 690 | |a eosinophil-associated dermatosis | ||
| 690 | |a granuloma faciale | ||
| 690 | |a interferon-gamma | ||
| 690 | |a interleukin-5 | ||
| 690 | |a JAK inhibitor | ||
| 690 | |a janus kinase | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n JAAD Case Reports, Vol 36, Iss , Pp 73-74 (2023) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2352512623001297 | |
| 787 | 0 | |n https://doaj.org/toc/2352-5126 | |
| 856 | 4 | 1 | |u https://doaj.org/article/1f2f710fa0a846978f686f95b8bdce8b |z Connect to this object online. |